
### [NCIT:C3246](http://purl.obolibrary.org/obo/NCIT_C3246)
**Label:** Mycosis Fungoides

**Subclasses:** [NCIT:C7802](http://purl.obolibrary.org/obo/NCIT_C7802) (Stage IV Mycosis Fungoides), [NCIT:C7798](http://purl.obolibrary.org/obo/NCIT_C7798) (Stage II Mycosis Fungoides), [NCIT:C7800](http://purl.obolibrary.org/obo/NCIT_C7800) (Stage III Mycosis Fungoides), [NCIT:C8687](http://purl.obolibrary.org/obo/NCIT_C8687) (Refractory Mycosis Fungoides), [NCIT:C7796](http://purl.obolibrary.org/obo/NCIT_C7796) (Stage I Mycosis Fungoides), [NCIT:C8686](http://purl.obolibrary.org/obo/NCIT_C8686) (Recurrent Mycosis Fungoides), 

**Class expressions from DL-Learner:**

- Thing 54.38%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39805](http://purl.obolibrary.org/obo/NCIT_C39805) (PSF-TFE3 Fusion Protein Expression))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39803](http://purl.obolibrary.org/obo/NCIT_C39803) (PRCC-TFE3 Fusion Protein Expression))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39802](http://purl.obolibrary.org/obo/NCIT_C39802) (Renal Cell Carcinoma Associated with inv(X)(p11;q12)))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39801](http://purl.obolibrary.org/obo/NCIT_C39801) (inv(X)(p11;q12)))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39800](http://purl.obolibrary.org/obo/NCIT_C39800) (Sickle Cell Trait))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39799](http://purl.obolibrary.org/obo/NCIT_C39799) (Loss of Chromosome 21))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39798](http://purl.obolibrary.org/obo/NCIT_C39798) (Loss of Chromosome 2))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39795](http://purl.obolibrary.org/obo/NCIT_C39795) (Loss of Chromosome 14q))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39788](http://purl.obolibrary.org/obo/NCIT_C39788) (MET Gene Mutation))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39787](http://purl.obolibrary.org/obo/NCIT_C39787) (Multiple Tumor Masses))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39786](http://purl.obolibrary.org/obo/NCIT_C39786) (Bilateral Disease))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39783](http://purl.obolibrary.org/obo/NCIT_C39783) (Retinal Hemangioblastoma))) 37.02%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39752](http://purl.obolibrary.org/obo/NCIT_C39752) (Refractory Disease))) 37.02%


